Dying woman's fight leads to nation's toughest PFAS law
Starting this year, it's America's strictest state law policing PFAS, compounds known as "forever chemicals." They are found in everyday products such as non-stick cookware and cosmetics and linked to childhood cancers and other health issues.
"It's in products. In humans. It's in animals. It's in the air. It's in the water. It's in fish," said Katrina Kessler, commissioner of the Minnesota Pollution Control Agency. "And we all need to think about exposure to PFAS and ways to mitigate PFAS."
Strande was 20 and dying of liver cancer when she testified before state lawmakers about the issue in 2023.
"PFAS have created a public health crisis that has plagued my community for nearly 60 years," Strande said during her testimony.
Minnesota's new law will reduce, then eliminate, the manufacture and sale of nonessential PFAS products by 2032. 3M, a multinational corporation headquartered near Minneapolis, developed PFAS and manufactured them for decades. According to the state, PFAS waste, discarded into landfills, leached into local groundwater.
"Don't drink the 3M cancer water became the running joke at my high school," Strande testified.
There's no definitive proof PFAS caused Strande's cancer, but her convictions inspired lawmakers to act.
Michael and Nora Strande, Amara's father and sister, see the law as her legacy.
"She had a drive like no one else I know," Nora said.
"She wasn't interested in being an adversary. She was interested in being a partner in solving the issue," Michael said.
3M told CBS News it supports "...regulations based on the best available science and established regulatory practices." The company said it will stop producing PFAS by the end of this year and agreed to pay the state $850 million for a PFAS clean-up.
"One person can make a difference. You just have to have the willingness to fight the good fight," Michael said.
Strande died five weeks before the bill became law.
Next steps in Sean "Diddy" Combs trial after partial verdict
Reporter's Notebook: When politicians cry wolf on fiscal restraint
Jimmy Swaggart, televangelist once mired in sex scandal, dies at 90
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
HRT ‘can raise breast cancer risk' in younger women
Hormone replacement therapy can raise the risk of breast cancer in some younger women, a Lancet study suggests. An international team of researchers found the treatment was not linked to young onset breast cancer overall. But oestrogen plus progestin therapy appears to increase breast cancer risk by 10 per cent. Meanwhile, oestrogen hormone therapy use appeared to decrease breast cancer risk by 14 per cent. Hormone replacement therapy is a treatment used to help menopause symptoms. There are different types of HRT, which is used to treat menopause symptoms, available. They contain different hormones: some are oestrogen products; others contain progestogen and other types have both. These medicines can be taken or used in different ways and work by replacing the hormones oestrogen and progesterone, which can fall to lower levels as women approach the menopause. Most studies examining links between hormone therapy and breast cancer risk have been explored in older women. Previous work, which has focused on women who have already been through the menopause, suggest that oestrogen plus progestin hormone therapy is a risk factor for breast cancer. The researchers, led by academics from the National Institute of Environmental Health Sciences in the US, wanted to explore the risks among younger women on hormone therapy – who may take these drugs after gynaecological surgery or during perimenopause. The new meta-analysis published in the journal, Lancet Oncology, examined data drawn from previous studies of 459,476 women aged 16 to 54 years old. Some two per cent of this group (8,455) developed young-onset breast cancer, which means the disease was diagnosed before they were 55 years old. And 15 per cent of women involved in the study reported using hormone therapy, with oestrogen plus progestin hormone therapy and oestrogen being the most common types. 'Although the strength of these associations might vary by age at first use, duration of use, gynaecological surgery status, and other factors, unopposed oestrogen hormone therapy use appears to decrease breast cancer risk and oestrogen plus progestin therapy appears to increase breast cancer risk,' the authors wrote. 'The findings can be used to augment clinical recommendations for hormone therapy use in young women, for whom guidance was previously scarce.' Dr Kotryna Temcinaite, the head of research communications at Breast Cancer Now, said: 'These results are largely in line with what we already know about taking HRT for menopausal symptoms and its effects on breast cancer risk – for most people, the risk of developing breast cancer because of taking HRT is small and is outweighed by the benefits. 'Taking HRT is a very personal decision and, as such, it's vital that everyone has the information they need on the benefits and risks, discusses them with their GP or specialist team and is supported to make the choice that's right for them.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
22 minutes ago
- Yahoo
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
27 minutes ago
- Yahoo
Trump Made Bizarre Request At Hospital After Assassination Attempt: Book
Donald Trump asked the doctor treating him for his gunshot wound last July if he could have a CT scan image because it's 'like an IQ test,' according to a new book. The Washington Post published an excerpt from '2024: How Trump Retook the White House and the Democrats Lost America' detailing the day of the assassination attempt on him in Butler, Pennsylvania. A portion of it contained the curious item of Trump making his scan request to the physician and walking down the hall with a phalanx of Secret Service agents to get the scan. Here's the rest of the passage: He asked to see the 'film' from the scan. The doctor said that wasn't done anymore, and offered him a written report. 'I want the film,' he repeated. [Co-campaign manager Susie Wiles] left to get a copy of the image, and while she was gone, one of the aides asked him why. 'It's like an IQ test,' Trump said. 'They tell you that your brain is good, so I just want to have that.' Wiles put the images in a manila envelope in her bag. Brain CT scans are used to detect tumors, bleeding, or other abnormalities, but they do not measure intelligence, according to Johns Hopkins Medicine. However, another type of scan, the MRI, is thought to indicate intellectual capacity as brain activity is tracked at rest, Caltech reported. A study showed that infants' IQ could potentially be predicted using the MRI. Trump has been known to obsess over IQ, and the timing of his request might have had to do with his race against then Democratic nominee Joe Biden. While Biden bore the brunt of concerns over cognitive ability at the time, Trump also faced questions. Biden withdrew from the race about a week later and was replaced by Vice President Kamala Harris. Trump, of course, won the election but has not quelled accusations of impairment. HuffPost has reached out to Trump's team for comment. Lawrence O'Donnell's Unfiltered Reaction To Bonkers Trump Presser Moment Says It All Trump's Tax Bill Plans To Decimate Medicaid. For One Group, The Cuts Will Be Unspeakably Cruel. From Name-Calling To Love-Bombing: Trump Mocked For DeSantis Flip-Flop
